Author:
Fujita Hiroshi,Hamaki Tamae,Handa Naoko,Ohwada Akira,Tomiyama Junji,Nishimura Shigeko
Publisher
Japanese Society for Lymphoreticular Tissue Research
Reference16 articles.
1. 1 Tartaglia AP, Goldberg JD, Berk PD, Wasserman LR: Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera. Semin Hematol 23:172-176, 1986
2. 2 Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, et al.: The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia : rationale and important changes. Blood 114:937-951, 2009
3. 3 McMullin MF: Idiopathic erythrocytosis : a disappearing entity. Hematology Am Soc Hematol Educ Program 629-635, 2009
4. 4 Scott LM, Tong W, Levine RL, Scott MA, Beer PA, et al: JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med 356:459-468, 2007
5. 5 Fujita H, Sakuma R, Tomiyama J, Hamaki T, Ohwada A, et al: Relationship between clotting activity and phosphatidylserine expression on erythrocyte membranes in polycythemia vera patients with the JAK2 V617F mutation. Arch Physiol Biochem 117:231-235, 2011
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献